PrimeraDx (Primera Biosystems)

About:

PrimeraDx offers multiplexed infectious disease assays that include scalable target amplification routine technology.

Website: http://www.primeradx.com

Twitter/X: PrimeraDx

Top Investors: Invus, National Cancer Institute, MPM Capital, Abingworth, InterWest Partners

Description:

PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.